Product NDC: | 0904-6125 |
Proprietary Name: | Terazosin Hydrochloride |
Non Proprietary Name: | Terazosin Hydrochloride |
Active Ingredient(s): | 10 mg/1 & nbsp; Terazosin Hydrochloride |
Administration Route(s): | ORAL |
Dosage Form(s): | CAPSULE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0904-6125 |
Labeler Name: | Major Pharmaceuticals |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA074823 |
Marketing Category: | ANDA |
Start Marketing Date: | 20091102 |
Package NDC: | 0904-6125-61 |
Package Description: | 100 CAPSULE in 1 BOX, UNIT-DOSE (0904-6125-61) |
NDC Code | 0904-6125-61 |
Proprietary Name | Terazosin Hydrochloride |
Package Description | 100 CAPSULE in 1 BOX, UNIT-DOSE (0904-6125-61) |
Product NDC | 0904-6125 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Terazosin Hydrochloride |
Dosage Form Name | CAPSULE |
Route Name | ORAL |
Start Marketing Date | 20091102 |
Marketing Category Name | ANDA |
Labeler Name | Major Pharmaceuticals |
Substance Name | TERAZOSIN HYDROCHLORIDE |
Strength Number | 10 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Adrenergic alpha-Antagonists [MoA],alpha-Adrenergic Blocker [EPC] |